National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007
Latest Action
Became Public Law No: 110-18.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007 (H.R. 1132) is a law enacted by the 110th Congress to continue funding and support for the National Breast and Cervical Cancer Early Detection Program. This program provides access to breast and cervical cancer screening and diagnostic services for underserved women, aiming to detect cancer early and reduce mortality rates. The bill was signed into law on April 20, 2007, ensuring the continuation of federal support for these preventive health services.
H.R. 1132 reauthorizes federal funding for a program that facilitates early detection of breast and cervical cancer among underserved populations, continuing efforts to improve women's health outcomes.
- Reauthorizes the National Breast and Cervical Cancer Early Detection Program to provide screening and diagnostic services.
- Targets underserved women who may lack access to regular cancer screening.
- Signed into law as Public Law No: 110-18 on April 20, 2007.
['Underserved women at risk for breast and cervical cancer', 'Health agencies administering cancer screening programs', 'Healthcare providers offering screening and diagnostic services']
['Implementation depends on continued federal funding appropriations.', 'Oversight mechanisms for program effectiveness and fund allocation are not detailed in the available summary.', 'Potential challenges in reaching all eligible underserved populations.']
This bill was passed by the House and signed into law during the 110th Congress, reflecting bipartisan support for continuing federal efforts to provide cancer screening services to underserved women. The legislation builds on existing public health initiatives aimed at reducing cancer mortality through early detection.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Improved early detection may reduce long-term healthcare costs associated with advanced cancer treatment.', 'Increased screening could lead to higher demand for diagnostic and treatment services.', 'Enhanced public health data collection on cancer incidence among underserved populations.']
Transparency considerations include monitoring the allocation and use of federal funds authorized by this act, as well as ensuring that program outcomes are reported publicly to assess effectiveness. The absence of detailed oversight provisions in the available documentation suggests a need for attention to accountability mechanisms in program implementation.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.